Early evaluation of patient risk for substantial weight gain during olanzapine treatment for schizophrenia, schizophreniform, or schizoaffective disorder
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-244X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Early evaluation of patient risk for substantial weight gain during olanzapine treatment for schizophrenia, schizophreniform, or schizoaffective disorder ; volume:8 ; number:1 ; day:15 ; month:9 ; year:2008 ; pages:1-14 ; date:12.2008
BMC psychiatry ; 8, Heft 1 (15.9.2008), 1-14, 12.2008
- Creator
-
Lipkovich, Ilya
- Contributor
-
Jacobson, Jennie G.
Hardy, Thomas A.
Hoffmann, Vicki Poole
SpringerLink (Online service)
- DOI
-
10.1186/1471-244X-8-78
- URN
-
urn:nbn:de:1111-2016030427445
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lipkovich, Ilya
- Jacobson, Jennie G.
- Hardy, Thomas A.
- Hoffmann, Vicki Poole
- SpringerLink (Online service)
Other Objects (12)
Therapeutic reference range for olanzapine in schizophrenia revised
Does Schizophrenia have a substantial genetic component?
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Modernizing cement manufacturing in China leads to substantial environmental gains
Olanzapine-induced mania
A Translational Bioengineering Course Provides Substantial Gains in Civic Scientific Literacy
Clinical patterns of metabolic syndrome in young, clinically stable, olanzapine-exposed patients with schizophrenia
Long-Term Assessment of Asenapine vs. Olanzapine in Patients with Schizophrenia or Schizoaffective Disorder
The substantial-gain-loss-ratio and the evaluation of individual labor income
A randomized, double-blind, placebo-controlled study of rapid-acting intramuscular olanzapine in Japanese patients for schizophrenia with acute agitation
Debt-to-equity Swaps in Eurozone´s Banking Sector: Minor Short-term Pain for Substantial Long-term Gain
Change in level of productivity in the treatment of schizophrenia with olanzapine or other antipsychotics
Therapeutic reference range for olanzapine in schizophrenia revised
Does Schizophrenia have a substantial genetic component?
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Modernizing cement manufacturing in China leads to substantial environmental gains
Olanzapine-induced mania
A Translational Bioengineering Course Provides Substantial Gains in Civic Scientific Literacy
Clinical patterns of metabolic syndrome in young, clinically stable, olanzapine-exposed patients with schizophrenia
Long-Term Assessment of Asenapine vs. Olanzapine in Patients with Schizophrenia or Schizoaffective Disorder
The substantial-gain-loss-ratio and the evaluation of individual labor income
A randomized, double-blind, placebo-controlled study of rapid-acting intramuscular olanzapine in Japanese patients for schizophrenia with acute agitation
Debt-to-equity Swaps in Eurozone´s Banking Sector: Minor Short-term Pain for Substantial Long-term Gain
Change in level of productivity in the treatment of schizophrenia with olanzapine or other antipsychotics
Therapeutic reference range for olanzapine in schizophrenia revised
Does Schizophrenia have a substantial genetic component?
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Modernizing cement manufacturing in China leads to substantial environmental gains
Olanzapine-induced mania
A Translational Bioengineering Course Provides Substantial Gains in Civic Scientific Literacy
Clinical patterns of metabolic syndrome in young, clinically stable, olanzapine-exposed patients with schizophrenia
Long-Term Assessment of Asenapine vs. Olanzapine in Patients with Schizophrenia or Schizoaffective Disorder
The substantial-gain-loss-ratio and the evaluation of individual labor income
A randomized, double-blind, placebo-controlled study of rapid-acting intramuscular olanzapine in Japanese patients for schizophrenia with acute agitation
Debt-to-equity Swaps in Eurozone´s Banking Sector: Minor Short-term Pain for Substantial Long-term Gain